The Recall Desk
Agency classClass IIOur severity:HighFDA (Drugs)·D-0577-2026·Announced 2026-06-10

Equaline ultra strength antacid tablets contain small metallic particles

Equaline Ultra Strength Antacid Tablets, calcium carbonate 1000 mg, are being recalled because of the presence of small metallic particles in the chewable tablets.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Metallic particles in a chewable tablet are a physical hazard capable of causing injury, a risk of harm with no injuries reported in the source.

Plain-English summary

Equaline Ultra Strength Antacid Tablets, calcium carbonate 1000 mg, 72 chewable tablets, distributed by SUPERVALU INC. of Eden Prairie, Minnesota, NDC 41163-171-68, are being recalled.

The stated reason is the presence of a foreign substance: small metallic particles in the chewable tablets. The FDA classified the action as Class II.

The affected lot is 1716089, expiring January 2029. Distribution was USA nationwide.

Consumers who have the affected lot should stop using it and return it to the place of purchase. Anyone injured after taking the tablets should seek medical advice.

The recalled product

Product
EQU ULTRA STRENGTH ANTACID ASSORTED FRUIT 171AF (CALCIUM CARBONATE)
Brand
EQU ULTRA STRENGTH ANTACID ASSORTED FRUIT 171AF
Manufacturer
Guardian Drug Co. Inc.
Category
Drug — Antacid tablet
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 1716089
  • expires: JAN- 2029.

UPCs (2)

  • 0041163466951
  • 0041163254183

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 23 recalled by Guardian Drug Co. Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 23 products in this recall →

Related recalls

Same manufacturer · Guardian Drug Co. Inc.

See all →

Same hazard · foreign object

See all →

Similar recalls